A Novel Proposal for Deep Learning-Based Diabetes Prediction: Converting Clinical Data to Image Data

An explainable Artificial Intelligence software system for predicting diabetes

Implementing diabetes surveillance systems is paramount to mitigate the risk of incurring substantial medical expenses. Currently, blood glucose is measured by minimally invasive methods, which involve extracting a small blood sample and transmitting it to a blood glucose meter. This method is deemed discomforting for individuals who are undergoing it. The present study introduces an Explainable Artificial Intelligence (XAI) system, which aims to create an intelligible machine capable of explaining expected outcomes and decision models. To this end, we analyze abnormal glucose levels by utilizing Bi-directional Long Short-Term Memory (Bi-LSTM) and Convolutional Neural Network (CNN). In this regard, the glucose levels are acquired through the glucose oxidase (GOD) strips placed over the human body. Later, the signal data is converted to the spectrogram images, classified as low glucose, average glucose, and abnormal glucose levels. The labeled spectrogram images are then used to train the individualized monitoring model. The proposed XAI model to track real-time glucose levels uses the XAI-driven architecture in its feature processing. The model's effectiveness is evaluated by analyzing the performance of the proposed model and several evolutionary metrics used in the confusion matrix. The data revealed in the study demonstrate that the proposed model effectively identifies individuals with elevated glucose levels.

A systematic review on diabetic retinopathy detection and classification based on deep learning techniques using fundus images

Diabetic retinopathy (DR) is the leading cause of visual impairment globally. It occurs due to long-term diabetes with fluctuating blood glucose levels. It has become a significant concern for people in the working age group as it can lead to vision loss in the future. Manual examination of fundus images is time-consuming and requires much effort and expertise to determine the severity of the retinopathy. To diagnose and evaluate the disease, deep learning-based technologies have been used, which analyze blood vessels, microaneurysms, exudates, macula, optic discs, and hemorrhages also used for initial detection and grading of DR. This study examines the fundamentals of diabetes, its prevalence, complications, and treatment strategies that use artificial intelligence methods such as machine learning (ML), deep learning (DL), and federated learning (FL). The research covers future studies, performance assessments, biomarkers, screening methods, and current datasets. Various neural network designs, including recurrent neural networks (RNNs), generative adversarial networks (GANs), and applications of ML, DL, and FL in the processing of fundus images, such as convolutional neural networks (CNNs) and their variations, are thoroughly examined. The potential research methods, such as developing DL models and incorporating heterogeneous data sources, are also outlined. Finally, the challenges and future directions of this research are discussed.

Pediatric diabetes prediction using deep learning

This study proposed a novel technique for early diabetes prediction with high accuracy. Recently, Deep Learning (DL) has been proven to be expeditious in the diagnosis of diabetes. The supported model is constructed by implementing ten hidden layers and a multitude of epochs using the Deep Neural Network (DNN)-based multi-layer perceptron (MLP) algorithm. We proceeded to meticulously fine-tune the hyperparameters within the fully automated DL architecture to optimize data preprocessing, prediction, and classification using a novel dataset of Mansoura University Children's Hospital Diabetes (MUCHD), which allowed for a comprehensive evaluation of the system's performance. The system was validated and tested using a sample of 548 patients, each with 18 significant features. Various validation metrics were employed to ensure the reliability of the results using cross-validation approaches with various statistical measures of accuracy, F-score, precision, sensitivity, specificity, and Dice similarity coefficient. The high performance of the proposed system can help clinicians accurately diagnose diabetes, with a remarkable accuracy rate of 99.8%. According to our analysis, implementing this method results in a noteworthy increase of 0.39% in the overall system performance compared to the current state-of-the-art methods. Therefore, we recommend using this method to predict diabetes.

Revolutionizing Early Disease Detection: A High-Accuracy 4D CNN Model for Type 2 Diabetes Screening in Oman

The surge of diabetes poses a significant global health challenge, particularly in Oman and the Middle East. Early detection of diabetes is crucial for proactive intervention and improved patient outcomes. This research leverages the power of machine learning, specifically Convolutional Neural Networks (CNNs), to develop an innovative 4D CNN model dedicated to early diabetes prediction. A region-specific dataset from Oman is utilized to enhance health outcomes for individuals at risk of developing diabetes. The proposed model showcases remarkable accuracy, achieving an average accuracy of 98.49% to 99.17% across various epochs. Additionally, it demonstrates excellent F1 scores, recall, and sensitivity, highlighting its ability to identify true positive cases. The findings contribute to the ongoing effort to combat diabetes and pave the way for future research in using deep learning for early disease detection and proactive healthcare.